Renaissance Technologies
KERX

Renaissance Technologies’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Renaissance Technologies’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-295,500
Closed -$2.95M – 3490
2015
Q2 		$2.95M Buy
+295,500
New +$3.17M 0.01% 1801
2014
Q2 		– Sell
-18,700
Closed -$319K – 3092
2014
Q1 		$319K Buy
+18,700
New +$282K ﹤0.01% 2503
2013
Q4 		– Sell
-991,100
Closed -$10M – 3110
2013
Q3 		$10M Buy
+991,100
New +$8.82M 0.02% 802

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ACM
Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

Renaissance Technologies's KERX Position: Q3 2015 in Review

Renaissance Technologies sold out of Keryx Biopharmaceuticals Inc (KERX) in Q3 2015, closing a stake of 295,500 shares — an estimated $2.95M sold.

Renaissance Technologies first reported a position in KERX in Q3 2013 and held it in 3 quarters. The position peaked at $10M in Q3 2013. 138 funds tracked by Wall St. Rank hold KERX as of Q3 2015.

  • Renaissance Technologies reported no remaining Keryx Biopharmaceuticals Inc position as of Q3 2015 after selling out during the quarter.
  • Renaissance Technologies sold 295,500 Keryx Biopharmaceuticals Inc shares in Q3 2015, an estimated $2.95M.
  • Renaissance Technologies first reported a position in Keryx Biopharmaceuticals Inc in Q3 2013 and held it in 3 quarters.
  • Renaissance Technologies's Keryx Biopharmaceuticals Inc position peaked at $10M in Q3 2013.
  • 138 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q3 2015.

Based on Renaissance Technologies's 13F filing for Q3 2015, filed 12 Nov 2015.